THOMAS KROCHALIS: Open Payments
NPI 1912371717 · MARTINSBURG, WV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$569 in 28 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $240 · 2025 $569
Food & beverage: $569
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $204 |
| Alkermes, Inc. | 4 | $90 |
| Janssen Pharmaceuticals, Inc | 4 | $84 |
| Teva Pharmaceuticals USA, Inc. | 3 | $75 |
| Indivior Inc. | 1 | $40 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $24 |
| E.R. Squibb & Sons, L.L.C. | 1 | $18 |
| Biogen, Inc. | 1 | $17 |
| Otsuka America Pharmaceutical, Inc. | 1 | $16 |
Products named: VRAYLAR, AUSTEDO XR, INVEGA SUSTENNA, ARISTADA, SUBLOCADE, SPRAVATO, LYBALVI, CAPLYTA.
Industry payments across WV — which companies pay providers there.
